Xy Capital LTD Zai Lab LTD Transaction History

Xy Capital LTD

  • $292 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023
BUY
$22.72 - $31.49 $3.17 Million - $4.4 Million
139,743 New
139,743 $3.4 Billion
Q1 2023

May 08, 2023
SELL
$30.21 - $48.1 $64,045 - $101,972
-2,120 Reduced 11.82%
15,820 $526 Million
Q4 2022

Feb 09, 2023
BUY
$22.28 - $38.71 $399,703 - $694,457
17,940 New
17,940 $551 Million

Others Institutions Holding ZLAB

# of Institutions
121
Shares Held
46.7M
Call Options Held
223K
Put Options Held
588K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.43B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Xy Capital LTD Portfolio

Follow Xy Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xy Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xy Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email